Sumitomo Mitsui Trust Group Inc. Sells 61,527 Shares of Xylem Inc. $XYL

Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of Xylem Inc. (NYSE:XYL) by 10.2% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 538,861 shares of the industrial products company’s stock after selling 61,527 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Xylem were worth $64,394,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. J. Stern & Co. LLP increased its stake in Xylem by 12,326.6% in the fourth quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after acquiring an additional 45,082,435 shares during the last quarter. Vanguard Group Inc. lifted its stake in Xylem by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 30,054,743 shares of the industrial products company’s stock worth $4,092,855,000 after purchasing an additional 152,507 shares during the last quarter. State Street Corp boosted its holdings in shares of Xylem by 2.6% in the 4th quarter. State Street Corp now owns 11,233,427 shares of the industrial products company’s stock worth $1,529,768,000 after purchasing an additional 280,221 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Xylem by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 6,357,278 shares of the industrial products company’s stock worth $862,364,000 after purchasing an additional 151,754 shares in the last quarter. Finally, Swedbank AB increased its position in shares of Xylem by 0.3% during the 1st quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company’s stock valued at $660,444,000 after purchasing an additional 18,759 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Xylem Trading Up 2.0%

Shares of NYSE XYL traded up $2.37 during midday trading on Friday, reaching $121.26. The company had a trading volume of 1,399,557 shares, compared to its average volume of 1,783,016. The stock has a market cap of $28.82 billion, a PE ratio of 30.16, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. Xylem Inc. has a one year low of $105.29 and a one year high of $154.27. The firm’s fifty day moving average price is $112.64 and its 200-day moving average price is $124.05. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.03. The business had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period last year, the company earned $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, equities research analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were issued a $0.43 dividend. The ex-dividend date was Thursday, May 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. Xylem’s dividend payout ratio (DPR) is currently 42.79%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the company. UBS Group boosted their target price on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Jefferies Financial Group upgraded shares of Xylem from a “hold” rating to a “buy” rating and increased their price target for the company from $130.00 to $140.00 in a research report on Thursday, June 25th. Barclays decreased their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 29th. JPMorgan Chase & Co. lowered their price objective on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Finally, Oppenheimer cut their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Xylem currently has a consensus rating of “Moderate Buy” and an average target price of $153.54.

Insider Activity at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This represents a 54.22% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The stock was purchased at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.32% of the stock is currently owned by company insiders.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.